Carlos Benites

Carlos Benites

Auto-generated profile, based on publicly available information

Carlos Benites

Ministerio de Salud Lima Peru

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2021 in Revista Peruana de Medicina Experimental Y Salud Pública
Verified
Journal Article
Open access
PDF file
EEErrea Errea
Errea Errea
MWMilagros Wong
Milagros Wong
LSLiz Senador
Liz Senador
ARAlicia Ramos
Alicia Ramos
KRKaren Ramos
Karen Ramos
MFMolly Franke
Molly Franke
Los adolescentes que viven con el VIH (AVVIH) tienen tasas más bajas de supresión virológica y tasas más altas de deterioro inmunológico en comparación con sus contrapartes mayores, colocándolos potencialmente en alto riesgo de enfermedad severa por SARS-CoV-2. Los AVVIH que están transicionando hacia el cuidado de adultos enfrentan dificultades adicionales para permanecer en el cuidado y adherirse al tratamiento antirretroviral. En esta sección especial reportamos el impacto observado en AVVIH transicionando al servicio de VIH para adultos durante la pandemia por SARS-CoV-2. En primer lugar, el acceso a la atención del VIH se ha visto perjudicado por la restricción del transporte público, la falta de antirretrovirales, y la suspensión de citas médicas y laboratoriales. Adicionalmente, dificultades financieras, incertidumbre sobre el futuro, estresores emocionales, alteración del estilo de vida y el temor de divulgar el diagnóstico involuntariamente han desafiado aún más la continuidad en la atención de esta población adolescente.

21 July 2022 in Sexually Transmitted Diseases
Verified
Journal Article
Closed access
AJAna Jorge-Berrocal
Ana Jorge-Berrocal
NVNatalia Vargas-Herrera
Natalia Vargas-Herrera
CBCarlos Benites
Carlos Benites
FSFabiola Salazar-Quispe
Fabiola Salazar-Quispe
MMMaritza Mayta-Barrios
Maritza Mayta-Barrios
NGNeisseria gonorrhoeae Surveillance Working Group
Neisseria gonorrhoeae Surveillance Working Group
Background: Currently, in Latin America, including Peru, the treatment of gonorrhea is still empiric and information regarding antimicrobial resistance is scarce in some countries because of the limited resources, which can contribute to the rising rates of reported multidrug-resistant gonococcal strains. In that context, it is mandatory to continuously monitor and report antimicrobial resistance in N. gonorrhoeae to update treatment recommendations. Methods: This descriptive study analyzed genital and anal samples from symptomatic patients who attended 15 sexually transmitted infections health facilities from 8 different regions in Peru during the years 2018 to 2019 within the framework of Sentinel Surveillance. After establishing the presumptive diagnosis, the isolates were sent to the Laboratory of Sexually Transmitted Bacteria of the National Institute of Health of Peru in Lima where the species were confirmed (N = 165) and susceptibility profiles were determined. Results: Among the 165 isolates, 95.2% corresponded to male patients, between 18 and 22 years of age (40.6%), half reported having a sexual partner and being heterosexual. Clinically, 89.7% manifested the presence of urethral exudate. Microbiology showed 95.2% of the isolates resistant to ciprofloxacin and 9.1% non-susceptible to azithromycin. Reduced susceptibility to ceftriaxone and cefixime was observed in 1.2% and 3.6% of the isolates respectively. All strains tested were susceptible to spectinomycin. Conclusions: This study demonstrated that in Peru, fluoroquinolones should not be recommended or used in N. gonorrhoeae infections due to the high percentage of resistant strains. In addition, nationwide access to gonococcal resistance testing, molecular diagnostics and antimicrobial stewardship should be implemented to control the spread of gonococcal antimicrobial resistance.

27 December 2022 in HIV Medicine
Verified
Journal Article
Closed access
NRNora Reyes
Nora Reyes
CBCarlos Benites
Carlos Benites
LGLisset García‐Fernández
Lisset García‐Fernández
MCMaria Calderon
Maria Calderon
FFFabián Fiestas
Fabián Fiestas
Ericson L GutierrezEricson L Gutierrez
Ericson L Gutierrez

19 September 2022 in ACTA MEDICA PERUANA
Verified
Journal Article
Open access
PDF file
RBRuben Dario Vasquez Becerra
Ruben Dario Vasquez Becerra
AVAna Vera
Ana Vera
RTRosa Terán
Rosa Terán
CBCarlos Benites
Carlos Benites